Shares of Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) have been assigned an average recommendation of "Hold" from the eleven brokerages that are covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, six have given a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $5.72.
Several research firms have recently issued reports on DH. Needham & Company LLC restated a "hold" rating on shares of Definitive Healthcare in a report on Thursday, January 16th. Barclays restated an "underweight" rating and set a $4.00 price target on shares of Definitive Healthcare in a research note on Monday, January 13th. Finally, Stephens assumed coverage on Definitive Healthcare in a report on Friday, December 20th. They issued an "equal weight" rating and a $5.00 price objective on the stock.
Check Out Our Latest Analysis on Definitive Healthcare
Definitive Healthcare Price Performance
Definitive Healthcare stock traded up $0.16 during mid-day trading on Thursday, hitting $4.87. 577,765 shares of the company were exchanged, compared to its average volume of 820,612. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. The business's 50 day simple moving average is $4.34 and its two-hundred day simple moving average is $4.47. The company has a market capitalization of $562.60 million, a P/E ratio of -1.57, a PEG ratio of 3.31 and a beta of 1.41. Definitive Healthcare has a 12-month low of $3.19 and a 12-month high of $10.62.
Definitive Healthcare (NASDAQ:DH - Get Free Report) last released its quarterly earnings results on Thursday, November 7th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.08 by ($0.03). The company had revenue of $62.70 million for the quarter, compared to analysts' expectations of $61.66 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. During the same period in the previous year, the business posted $0.01 EPS. Analysts forecast that Definitive Healthcare will post 0.15 earnings per share for the current fiscal year.
Insider Buying and Selling at Definitive Healthcare
In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of the firm's stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the sale, the insider now directly owns 433,830 shares in the company, valued at approximately $2,039,001. This trade represents a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 14.84% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of DH. The Manufacturers Life Insurance Company grew its holdings in Definitive Healthcare by 17.0% during the second quarter. The Manufacturers Life Insurance Company now owns 22,896 shares of the company's stock worth $125,000 after acquiring an additional 3,332 shares during the period. Glenmede Trust Co. NA grew its holdings in Definitive Healthcare by 41.1% during the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company's stock worth $82,000 after acquiring an additional 5,362 shares during the period. Nisa Investment Advisors LLC grew its holdings in Definitive Healthcare by 3,652.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company's stock worth $29,000 after acquiring an additional 6,794 shares during the period. Point72 DIFC Ltd grew its holdings in Definitive Healthcare by 759.9% during the third quarter. Point72 DIFC Ltd now owns 9,296 shares of the company's stock worth $42,000 after acquiring an additional 8,215 shares during the period. Finally, SG Americas Securities LLC grew its holdings in Definitive Healthcare by 44.6% during the fourth quarter. SG Americas Securities LLC now owns 27,189 shares of the company's stock worth $112,000 after acquiring an additional 8,387 shares during the period. 98.67% of the stock is owned by institutional investors and hedge funds.
Definitive Healthcare Company Profile
(
Get Free ReportDefinitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
Further Reading
Before you consider Definitive Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Definitive Healthcare wasn't on the list.
While Definitive Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
